sepsi
result
wide
spectrum
infecti
agent
common
caus
mortal
morbid
worldwid
lead
million
annual
death
children
year
previous
sepsi
defin
system
inflammatori
respons
syndrom
sir
presenc
result
suspect
proven
infect
surviv
sepsi
campaign
infect
could
bacteri
viral
fungal
cultur
diagnost
method
might
help
identif
variou
virus
could
caus
sepsi
influenc
age
underli
immun
respiratori
viral
infect
rvi
among
infant
caus
morbid
limit
data
exist
proport
sepsi
numer
case
clinic
deterior
sepsi
remain
without
bacteri
evid
thu
virus
may
also
consid
caus
respiratori
virus
ubiquit
surround
children
common
sourc
respiratori
infect
among
healthi
immunocompromis
individu
sever
respiratori
virus
may
also
caus
sever
respiratori
diseas
mainli
infant
also
children
virus
well
known
influenza
virus
respiratori
syncyti
viru
rsv
coronaviru
cov
human
metapneumoviru
hmpv
parainfluenza
virus
type
piv
adenoviru
av
enterovirus
ev
human
rhinoviru
hrv
human
bocaviru
hbov
despit
clinic
expans
rvi
usual
consid
clinic
signific
among
septic
patient
influenza
one
common
caus
viral
sepsi
children
highest
rate
hospit
number
manag
pediatr
sepsi
arrang
accord
age
immun
capac
child
sever
site
sourc
current
studi
etiolog
nosocomi
sepsi
aim
current
studi
evalu
proport
respiratori
viral
pathogen
infant
two
year
age
possibl
sepsi
prospect
studi
perform
hacettep
univers
medic
faculti
ihsan
child
hospit
turkey
decemb
decemb
tertiari
care
hospit
bed
admiss
year
also
includ
transplant
unit
patient
includ
studi
sepsi
symptom
defin
surviv
sepsi
campaign
inform
record
includ
clinic
demograph
characterist
medic
histori
complaint
admiss
physic
examin
laboratori
find
type
infect
bacteremia
pneumonia
durat
hospit
prognosi
nasopharyng
swab
specimen
collect
pediatr
patient
sepsi
age
month
virolog
depart
hospit
process
clinic
specimen
pediatr
depart
airway
secret
obtain
nasopharyng
swab
analyz
use
multiplex
revers
transcriptas
polymeras
chain
reaction
detect
viral
pathogen
within
hour
initi
antibiot
therapi
patient
die
treatment
includ
assess
mortal
death
caus
sampl
infant
age
month
suspect
sepsi
receiv
microbiolog
laboratori
test
respiratori
viru
infect
studi
period
elig
inclus
newborn
patient
older
month
without
sepsi
diagnosi
exclud
sampl
test
result
failur
pcr
insuffici
sampl
evalu
loss
blood
collect
inocul
bactec
aerob
cultur
bottl
bd
bactec
blood
cultur
system
antibiot
administr
first
hour
patient
evalu
urin
cultur
collect
patient
cerebrospin
fluid
cultur
sent
patient
sign
mening
sepsi
ca
defin
presenc
posit
blood
cultur
sir
criteria
within
hour
hospit
admiss
sepsi
defin
sepsi
day
hospit
empir
therapi
defin
therapi
institut
microbiolog
evid
infect
empir
therapi
switch
accord
suscept
test
pathogen
resist
empir
therapi
studi
approv
ethic
committe
hacettep
univers
number
go
inform
consent
obtain
parent
legal
guardian
particip
specimen
receiv
inpati
infant
sepsi
symptom
analyz
multiplex
detect
viral
pathogen
test
sampl
virus
influenza
viru
piv
human
adenoviru
rsv
rsv
b
cov
ev
hrv
hbov
cov
cov
nucleic
acid
isol
perform
gene
ribospin
vrd
ii
isol
kit
seoul
korea
pcr
method
carri
seegen
detect
kit
seoul
korea
statist
analys
perform
use
ibm
spss
window
version
chicago
illinoi
descript
statist
use
summar
particip
baselin
characterist
includ
median
continu
variabl
number
total
percentag
categor
variabl
test
use
compar
baselin
characterist
categor
variabl
age
durat
hospit
day
laboratori
find
tabl
comparison
group
categor
variabl
season
gender
symptom
clinic
find
tabl
made
use
test
statist
signific
defin
p
valu
less
sinc
could
predict
patient
count
studi
begin
power
analysi
end
studi
assess
presenc
factor
among
season
power
total
infant
sepsi
enrol
studi
studi
period
nasopharyng
swab
collect
patient
compar
patient
among
three
group
patient
n
viral
posit
nasopharyng
swab
patient
n
proven
bacteri
infect
bacteremia
mening
without
viral
infect
patient
n
without
pathogen
detect
viral
bacteri
patient
urinari
tract
infect
median
age
group
month
month
month
respect
patient
male
three
group
statist
signific
differ
found
group
term
gender
p
age
p
tabl
viral
infect
group
n
patient
underli
diseas
frequent
underli
diseas
prematur
n
bacteri
infect
group
gastrointestin
immunodefici
diseas
commonli
seen
rate
n
patient
underli
diseas
proven
infect
agent
group
neurolog
n
immunodefici
n
diseas
common
underli
diseas
patient
underli
diseas
accord
season
distribut
winter
spring
patient
sepsi
mostli
viral
infect
howev
summer
autumn
patient
mostli
could
prove
infect
agent
season
distribut
significantli
differ
three
group
p
empir
therapi
start
patient
switch
accord
test
result
clinic
statu
patient
patient
bacteri
sepsi
longest
durat
hospit
median
day
although
pediatr
intens
care
unit
picu
stay
rate
mortal
rate
differ
group
overal
mortal
rate
n
mortal
rate
n
four
patient
rvi
five
patient
confirm
infect
two
patient
bacteremia
rvi
die
howev
statist
signific
differ
group
term
durat
hospit
p
tabl
symptom
clinic
find
patient
present
tabl
cough
symptom
statist
signific
group
p
highest
rate
viral
infect
group
p
laboratori
find
patient
median
thrombocyt
count
lower
bacteri
infect
group
other
p
differ
paramet
white
blood
cell
count
activ
prothrombin
time
intern
normal
ratio
protein
tabl
total
patient
mortal
five
infect
agent
one
thrombocytopenia
hand
six
infecti
agent
five
thrombocytopenia
three
patient
viral
infect
two
patient
bacteri
viral
infect
howev
patient
thrombocytopenia
viral
infect
patient
thrombocytopenia
proven
infecti
group
thrombocytopenia
bacteri
infecti
group
p
age
season
hospit
durat
cough
thrombocyt
count
evalu
multivari
analysi
found
cough
increas
risk
viral
infect
ci
addit
evalu
patient
two
group
n
ca
n
differ
found
two
group
term
age
sex
distribut
season
durat
hospit
picu
stay
mortal
rate
viral
infect
rate
howev
n
patient
ca
group
underli
diseas
group
patient
sever
underli
diseas
prematur
neurolog
diseas
statist
signific
differ
group
regard
bacteri
bloodstream
infect
rate
p
group
n
patient
bacteremia
wherea
ca
group
n
patient
bacteri
infect
viral
infect
rate
equal
group
tabl
patient
receiv
antibiot
sepsi
diagnosi
prospect
evalu
group
infant
rvi
one
month
two
year
possibl
sepsi
tertiari
hospit
viru
detect
pediatr
depart
import
issu
consid
contribut
success
antibiot
stewardship
provid
specif
ratifi
algorithm
implement
clinic
although
evid
still
lack
use
multiplex
detect
respiratori
virus
provid
medic
econom
benefit
pediatr
patient
potenti
benefit
viru
detect
may
aris
earli
implement
effect
isol
infect
control
measur
prevent
viral
spread
also
prevent
use
unnecessari
antibiot
frequenc
rvi
observ
studi
seem
twice
much
proven
bacteri
sepsi
howev
distinct
viral
bacteri
sepsi
clinic
andor
laboratori
find
difficult
case
rvi
could
differenti
case
posit
bacteri
blood
cultur
clinic
sepsi
clinic
present
rvi
gener
present
respiratori
symptom
albeit
clinic
characterist
heterogen
compar
bacteri
infect
cough
occur
viral
infect
studi
add
view
white
blood
count
protein
suitabl
differenti
bacteri
viral
infect
hand
thrombocytopenia
common
case
proven
bacteri
infect
decreas
thrombocyt
count
often
seen
patient
develop
sever
sepsi
well
develop
thrombocytopenia
septic
episod
recogn
associ
mortal
therefor
bacteri
sepsi
strongli
consid
differenti
diagnosi
patient
thrombocytopenia
clinic
sepsi
find
patient
receiv
antibiot
sepsi
diagnosi
could
interfer
blood
cultur
test
bacteria
reason
cdc
recommend
obtain
cultur
start
antimicrobi
common
respiratori
virus
usual
show
typic
season
distribut
temper
climat
best
exampl
rsv
influenza
occasion
hmpv
usual
peak
winter
studi
patient
sepsi
diagnos
rvi
winter
spring
season
two
year
period
hrv
seen
throughout
season
rsv
influenza
cov
seen
season
except
summer
sepsi
caus
viral
infect
mostli
winter
could
explain
due
respiratori
viru
epidem
often
seen
influenza
influenc
leukocyt
function
rel
vitamin
defici
wintertim
import
role
modul
innat
cellular
immun
found
rv
infect
seen
throughout
year
especi
autumn
spring
evalu
patient
rv
infect
studi
countri
indic
rv
infect
seen
year
et
al
found
rv
infect
detect
especi
winter
spring
anoth
studi
rv
infect
seen
frequent
earli
spring
caus
sepsi
import
durat
hospit
sever
diseas
studi
patient
bacteri
sepsi
longest
durat
hospit
median
day
although
pediatr
intens
care
unit
picu
stay
rate
mortal
rate
differ
group
statist
signific
differ
group
term
durat
hospit
p
could
relat
patient
bacteremia
longer
antibiot
treatment
durat
addit
patient
rvi
infecti
mortal
rate
picu
stay
rate
show
us
consid
patient
sepsi
term
rvi
due
rate
mortal
picu
stay
miggin
et
al
investig
critic
ill
patient
usa
detect
viral
infect
may
play
signific
yet
unrecogn
role
overal
outcom
icu
studi
hrv
influenza
commonli
seen
virus
rate
respect
figur
report
influenza
caus
increas
risk
sepsi
also
know
hrv
associ
sever
respiratori
infect
patient
immunocompromis
chronic
lung
sepsi
caus
hrv
rare
report
kim
et
al
state
patient
sepsi
patient
confirm
hrv
also
patient
prematur
congenit
cardiac
diseas
underli
diseas
risk
rsv
infect
take
detect
rate
rvi
possibl
conclud
infect
virus
lead
clinic
find
sepsi
infant
result
show
identif
rv
infant
sepsi
frequent
realli
import
sever
reason
respiratori
isol
specif
therapeut
influenza
infect
howev
studi
design
allow
infer
causal
relationship
sinc
control
group
without
sepsi
possibl
case
identifi
virus
caus
symptom
also
possibl
case
receiv
antibiot
collect
blood
cultur
caus
infect
might
still
bacteria
even
rv
detect
wide
rang
clinic
find
sepsi
cough
increas
risk
viral
infect
patient
sepsi
studi
popul
kidszun
et
al
show
increas
episod
apnea
bradycardia
respiratori
deterior
common
neonat
detect
rvi
treat
possibl
bacteri
emphas
septic
infant
need
prolong
increas
respiratori
support
rvi
kept
mind
result
support
patient
present
cough
evalu
respiratori
tract
virus
sepsi
pediatr
age
group
rvi
account
nosocomi
infect
infect
children
caus
studi
compar
patient
accord
two
group
sepsi
sepsi
rvi
seen
similar
group
studi
critic
ill
patient
show
viral
infect
present
either
alon
hospit
bacteri
infect
associ
increas
risk
mortal
pneumonia
acut
respiratori
distress
syndrom
respiratori
failur
diarrhea
sepsi
septic
shock
studi
also
conclud
coincid
infect
show
strong
associ
advers
studi
durat
hospit
picu
stay
mortal
death
similar
statist
signific
differ
group
regard
bacteri
bloodstream
infect
rate
p
possibl
confid
detect
actual
preval
rv
infect
howev
applic
sensit
detect
techniqu
immedi
led
dilemma
preval
asymptomat
infect
rv
studi
high
frequenc
rv
could
attribut
colon
mechan
surviv
rv
nare
absenc
could
detect
coincident
howev
patient
sepsi
consid
n
patient
rv
nasopharyng
swab
bacteri
infect
time
patient
receiv
antibiot
sepsi
diagnosi
could
interfer
blood
cultur
test
bacteria
reason
found
cdc
recommend
obtain
cultur
start
antimicrobi
therapi
studi
also
limit
includ
small
sampl
size
result
viral
infect
rate
appear
vari
substanti
differ
center
base
upon
limit
prior
report
infant
anoth
limit
detect
nucleic
acid
respiratori
tract
infant
could
repres
result
prolong
shed
preced
infect
even
colon
rather
acut
infect
anoth
limit
obtain
respiratori
sampl
specif
begin
clinic
find
sepsi
outpati
popul
abl
collect
specimen
upon
admiss
emerg
depart
despit
mani
limit
first
infant
popul
studi
document
rvi
among
patient
sepsi
countri
identif
caus
pathogen
provid
opportun
select
ideal
treatment
improv
surviv
rate
overal
patient
outcom
reduc
hospit
durat
overal
hospit
well
research
focu
place
rvi
sepsi
whether
virus
caus
sepsi
colon
nasopharynx
could
solv
prospect
studi
serial
quantit
pcr
analys
asymptomat
septic
ill
nonsept
children
believ
conclus
signific
viral
etiolog
patient
sepsi
underdiagnos
clinician
warrant
diagnos
rvi
earli
may
help
clinic
decis
treatment
strategi
author
state
explicitli
conflict
interest
connect
studi
